Danaher
Top Five Articles on 360Dx Last Week: Mobile Phlebotomy Company Fraud; Quest, Agilent Deal; and More
Last week, readers were most interested in a guilty plea by a mobile phlebotomy company alleged to have engaged in a $7.5 million scheme.
Danaher Q4 Revenues Rise 3 Percent Despite Difficulties in China
The firm's Life Sciences segment saw 8 percent growth year over year, while the Diagnostics sector rose 3 percent in the quarter.
JP Morgan Healthcare Conference, Day 2: Labcorp, Abbott, Thermo Fisher Scientific, Roche, More
Highlights from the first day included updates on several firms' COVID testing businesses, and details about a recent Thermo Fisher Scientific acquisition.
Invitae Sells Archer NGS Research Assays to Integrated DNA Technologies for $48M
IDT has acquired the VariantPlex, FusionPlex, LiquidPlex, and Immunoverse panels, powered by Invitae's anchored multiplex PCR (AMP) technology.
In Brief This Week: Abbott, Danaher, Lucira Health, Novacyt
News items for the week of Dec. 5, 2022.
Nov 7, 2022
Cepheid Nabs CE Mark for Group B Strep Test
Jul 25, 2022
Apr 25, 2022
Apr 21, 2022
Danaher Q1 Revenues Rise 12 Percent
Jan 27, 2022
Danaher Q4 Revenues Rise 21 Percent
Dec 2, 2021